Displaying all 19 drugs
Hepatitis B Vaccine (Recombinant)
Hepatitis B Vaccine is an ingredient in the EMA-withdrawn product Quintanrix. It is marketed in Canada as Engerix B. It is also a part of Twinrix (Hep A/Hep B vaccine) available also in Canada.
The hepatitis B virus induces a severe form of viral hepatitis. Other causative agents are hepatitis...
Approved
Withdrawn
Matched Synonyms: … Hepatitis B virus hbsag surface protein antigen ... Hepatitis B surface antigen ... Hepatitis-B surface antigen …
Matched Name: … Hepatitis B Vaccine (Recombinant) …
Matched Description: … It is estimated that the reservoir of persistent hepatitis B surface antigen carriers amounts to 350 ... Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses. ... Hepatitis D virus, a defective virus requiring the “keeper function” of the hepatitis B virus, occurs …
Matched Salts name: … Hepatitis B virus subtype ADW HBSAG surface protein antigen ... Hepatitis B virus subtype ADW2 HBSAG surface protein antigen …
Matched Categories: … Inactivated Hepatitis B Virus Vaccine ... Hepatitis B Surface Antigens ... Hepatitis B Surface Antigens, drug effects ... haemophilus influenzae B and hepatitis B ... Hepatitis B Antigens …
Matched Products: … VAKSIN HEPATITIS B REKOMBINAN ... VACUNADE LA HEPATITIS B (RADN) ... SII Hepatitis-B Vaccine (rDNA)(Adult)-Single Dose 1ml …
Matched Name: … Hepatitis B Vaccine (Recombinant) …
Matched Description: … It is estimated that the reservoir of persistent hepatitis B surface antigen carriers amounts to 350 ... Other causative agents are hepatitis A virus, and the non-A, non-B hepatitis viruses. ... Hepatitis D virus, a defective virus requiring the “keeper function” of the hepatitis B virus, occurs …
Matched Salts name: … Hepatitis B virus subtype ADW HBSAG surface protein antigen ... Hepatitis B virus subtype ADW2 HBSAG surface protein antigen …
Matched Categories: … Inactivated Hepatitis B Virus Vaccine ... Hepatitis B Surface Antigens ... Hepatitis B Surface Antigens, drug effects ... haemophilus influenzae B and hepatitis B ... Hepatitis B Antigens …
Matched Products: … VAKSIN HEPATITIS B REKOMBINAN ... VACUNADE LA HEPATITIS B (RADN) ... SII Hepatitis-B Vaccine (rDNA)(Adult)-Single Dose 1ml …
Hepatitis A Vaccine
Hepatitis A viral infection can lead to significant morbidity and mortality, with signs and symptoms that include anorexia, nausea, vomiting, and liver failure. Known by several trade names, such as Havrix and Twinrix, the Hepatitis A vaccine has been formulated for immunization against hepatitis A virus (HAV) infection and safely...
Approved
Matched Synonyms: … Hepatitis A vaccine, inactivated …
Matched Name: … Hepatitis A Vaccine …
Matched Description: … formulated for immunization against hepatitis A virus (HAV) infection and safely confers strong protection ... [A199185,L12756] In the US, the approved vaccine is inactivated while live Hepatitis A vaccines are currently ... Hepatitis A viral infection can lead to significant morbidity and mortality, with signs and symptoms …
Matched Salts name: … Hepatitis A virus strain HM175 antigen (formaldehyde inactivated) ... Hepatitis A virus strain CR 326F antigen (formaldehyde inactivated) …
Matched Categories: … Inactivated Hepatitis A Virus Vaccine ... Viral Hepatitis Vaccines …
Matched Products: … VAQTA ® 50 U VACUNA CONTRA LA HEPATITIS A (PURIFICADA E INACTIVADA) ... Havrix (Hepatitis A-Impfstoff) 1440 El.U/ml - Injektionssuspension in einer Fertigspritze ... Havrix (Hepatitis A-Impfstoff) Junior 720 El.U/0,5 ml - Injektionssuspension in einer Fertigspritze …
Matched Name: … Hepatitis A Vaccine …
Matched Description: … formulated for immunization against hepatitis A virus (HAV) infection and safely confers strong protection ... [A199185,L12756] In the US, the approved vaccine is inactivated while live Hepatitis A vaccines are currently ... Hepatitis A viral infection can lead to significant morbidity and mortality, with signs and symptoms …
Matched Salts name: … Hepatitis A virus strain HM175 antigen (formaldehyde inactivated) ... Hepatitis A virus strain CR 326F antigen (formaldehyde inactivated) …
Matched Categories: … Inactivated Hepatitis A Virus Vaccine ... Viral Hepatitis Vaccines …
Matched Products: … VAQTA ® 50 U VACUNA CONTRA LA HEPATITIS A (PURIFICADA E INACTIVADA) ... Havrix (Hepatitis A-Impfstoff) 1440 El.U/ml - Injektionssuspension in einer Fertigspritze ... Havrix (Hepatitis A-Impfstoff) Junior 720 El.U/0,5 ml - Injektionssuspension in einer Fertigspritze …
Bulevirtide
Hepatitis D is considered the most severe type of viral hepatitis and leads to the rapid development of cirrhosis, severe decompensation of liver function, and an increased risk of mortality.[A226340,L30235] Until recently, there have been extremely limited treatments available for Hepatitis D infection. Bulevirtide, also known as Hepcludex, is a...
Approved
Investigational
Matched International brands: … Myrcludex B …
Matched Description: … Hepatitis D is considered the most severe type of viral hepatitis and leads to the rapid development ... [A226305] Bulevirtide, also known as Hepcludex, is a first-in-class entry inhibitor for the treatment ... of cirrhosis, severe decompensation of liver function, and an increased risk of mortality. …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … Hepatitis D is considered the most severe type of viral hepatitis and leads to the rapid development ... [A226305] Bulevirtide, also known as Hepcludex, is a first-in-class entry inhibitor for the treatment ... of cirrhosis, severe decompensation of liver function, and an increased risk of mortality. …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Durvalumab
Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody and a novel immune-checkpoint inhibitor for cancer treatment. Produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture, durvalumab is a programmed death-ligand 1 (PD-L1) blocking antibody that works to promote normal immune responses that attack tumour...
Approved
Investigational
Matched Description: … Durvalumab is a human immunoglobulin G1 kappa (IgG1κ) monoclonal antibody and a novel immune-checkpoint ... recombinant DNA technology in Chinese Hamster Ovary (CHO) cell suspension culture,[L12621] durvalumab is a ... unresectable non-small cell lung cancer (NSCLC), only if PD-L1 is expressed in ≥ 1% of tumour cells and …
Matched Categories: … PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors ... Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents ... MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES …
Matched Categories: … PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors ... Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents ... MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES …
Hepatitis B immune globulin
Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection in patients transplanted for hepatitis B. Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. Therefore, the hepatitis-B vaccines are cancer-preventing vaccines. According to the Centers for Disease Control...
Approved
Investigational
Matched Synonyms: … Human hepatitis B virus immune globulin ... Hepatitis B immune globulin ... Hepatitis B immune globulin human …
Matched Name: … Hepatitis B immune globulin …
Matched Description: … HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen ... Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection ... Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. …
Matched Categories: … hepatitis B immunoglobulin ... Virus Neutralization ... Amino Acids, Peptides, and Proteins ... Immune Sera and Immunoglobulins …
Matched Products: … HEPATECT®CP 500 UI (INMUNOGLOBULINA HUMANA CONTRA EL VIRUS DE LA HEPATITIS B). ... HEPATECT ® CP 2000 U.IX 40ML (INMUNOGLOBULINAHUMANAHIPERINMUNECONTRA EL VIRUS DE LA HEPATITIS B) ... HEPATECT® CP X 2 ML …
Matched Name: … Hepatitis B immune globulin …
Matched Description: … HBIG is prepared from the plasma of donors who have high antibody levels of the hepatitis B surface antigen ... Long-term hepatitis B immune globulin (HBIG) has been shown to reduce hepatitis B virus (HBV) reinfection ... Infection with hepatitis B may lead to hepatocellular carcinoma, a type of liver cancer. …
Matched Categories: … hepatitis B immunoglobulin ... Virus Neutralization ... Amino Acids, Peptides, and Proteins ... Immune Sera and Immunoglobulins …
Matched Products: … HEPATECT®CP 500 UI (INMUNOGLOBULINA HUMANA CONTRA EL VIRUS DE LA HEPATITIS B). ... HEPATECT ® CP 2000 U.IX 40ML (INMUNOGLOBULINAHUMANAHIPERINMUNECONTRA EL VIRUS DE LA HEPATITIS B) ... HEPATECT® CP X 2 ML …
Antihemophilic factor human
Antihemophilic factor human, also known as Coagulation Factor VIII or Anti-Hemophilic Factor (AHF), is a non-recombinant, lyophilized concentrate of coagulation factor VIII, an endogenous protein and essential component of the coagulation cascade. Antihemophilic factor is manufactured with reduced amounts of von Willebrand Factor antigen (VWF:Ag) and purified from extraneous plasma-derived...
Approved
Matched Synonyms: … F8 protein, human …
Matched Description: … Factor VIII, but does not contain the B-domain, which has no known biological function and [DB11607] ... blood-borne diseases such as HIV and Hepatitis, which in part contributed to the Tainted Blood Scandal ... Antihemophilic factor is manufactured with reduced amounts of von Willebrand Factor antigen (VWF:Ag) …
Matched Mixtures name: … Haemate P Powder and solvent for solution for injection or infusion ... Wilate 500, 500 IU VWF/500 IU FVIII, Powder and Solvent for Solution for Injection ... Wilate 1000, 1000 IU VWF/1000 IU FVIII, Powder and Solvent for Solution for Injection …
Matched Categories: … Hemophilia A ... Protein Precursors ... Blood and Blood Forming Organs ... Amino Acids, Peptides, and Proteins …
Matched Products: … NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU ... NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250 IU ... NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000 IU …
Matched Description: … Factor VIII, but does not contain the B-domain, which has no known biological function and [DB11607] ... blood-borne diseases such as HIV and Hepatitis, which in part contributed to the Tainted Blood Scandal ... Antihemophilic factor is manufactured with reduced amounts of von Willebrand Factor antigen (VWF:Ag) …
Matched Mixtures name: … Haemate P Powder and solvent for solution for injection or infusion ... Wilate 500, 500 IU VWF/500 IU FVIII, Powder and Solvent for Solution for Injection ... Wilate 1000, 1000 IU VWF/1000 IU FVIII, Powder and Solvent for Solution for Injection …
Matched Categories: … Hemophilia A ... Protein Precursors ... Blood and Blood Forming Organs ... Amino Acids, Peptides, and Proteins …
Matched Products: … NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500 IU ... NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 250 IU ... NUWIQ POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 1000 IU …
Relatlimab
Relatlimab is a human IgG4 monoclonal antibody and novel immune checkpoint inhibitor that targets lymphocyte activation gene-3 (LAG-3).[A246165,L41265] It was the first commercially developed anti-LAG-3 antibody, entering clinical trials in 2013, and has garnered interest in the treatment of a variety of cancers, including leukemia and melanoma. As immune checkpoint...
Approved
Investigational
Matched Description: … Relatlimab is a human IgG4 monoclonal antibody and novel immune checkpoint inhibitor that targets lymphocyte ... has garnered interest in the treatment of a variety of cancers, including leukemia[A246160] and melanoma ... [L41265,L41300] It was the first anti-LAG-3 antibody to demonstrate benefit in a Phase 3 study, as well …
Matched Categories: … nivolumab and relatlimab ... Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents …
Matched Categories: … nivolumab and relatlimab ... Amino Acids, Peptides, and Proteins ... Antineoplastic and Immunomodulating Agents …
Galactose
Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer, Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. There are even proposals for its use in accelerating senescence in mice, rats, and Drosophila, for its association with ovarian cancer, or even...
Approved
Investigational
Matched Description: … Galactose has been used in trials studying the treatment and diagnosis of Hepatitis C, Hepatic Cancer ... As a naturally occurring sugar, it may be found in a number dairy products. ... , Wilsons Disease, Diabetic Macular Oedema, and Focal Segmental Glomerulosclerosis, among others. …
Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle (VLP) vaccine
Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV-2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated to the hepatitis B surface antigen . Virus-like particles (VLPs) are protein-based vaccines that stimulate high immune responses because of the VLPs’...
Investigational
Matched Synonyms: … RBD SARS-CoV-2 HBsAg VLP vaccine …
Matched Name: … Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle …
Matched Description: … Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV ... -2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated ... to the hepatitis B surface antigen[A226593]. …
Matched Name: … Receptor binding domain (RBD) SARS-CoV-2 (COVID-19) hepatitis B surface antigen (HBsAg) virus-like particle …
Matched Description: … Receptor binding domain SARS-CoV-2 Hepatitis B surface antigen virus-like particle vaccine (RBD SARS-CoV ... -2 HBsAg VLP vaccine), is a virus-like particle vaccine candidate where the RBD antigen is conjugated ... to the hepatitis B surface antigen[A226593]. …
Tuvirumab
Investigational
Matched Synonyms: … Immunoglobulin g 1 (human monoclonal pe1-1 anti-hepatitis b virus surface antigen), disulfide with human ... Immunoglobulin g1, anti-(hepatitis b virus surface antigen) (human monoclonal pe1-1 .gamma.1-chain), ... Immunoglobulin g 1 (human monoclonal pe1-1 anti-hepatitis b virus surface antigen), disulfide with human …
Lenvervimab
Investigational
Matched Synonyms: … Immunoglobulin g1, anti-(hepatitis b surface antigen) (human monoclonal gc1102 .gamma.1-chain), disulfide ... Hepatitis B virus neutralizing human monoclonal antibody ... Recombinant hepatitis B human immunoglobulin …
Exbivirumab
Exbivirumab is an investigational monoclonal antibody. It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface antigen.
Investigational
Matched Synonyms: … Immunoglobulin g, anti-(hepatitis b surface antigen) (human monoclonal 19.79.5 heavy chain), disulfide …
Matched Description: … to the hepatitis B virus (HBV) surface antigen. ... It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies …
Matched Description: … to the hepatitis B virus (HBV) surface antigen. ... It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies …
Libivirumab
Libivirumab is an investigational monoclonal antibody. It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies to the hepatitis B virus (HBV) surface antigen.
Investigational
Matched Synonyms: … Immunoglobulin g, anti-(hepatitis b surface antigen) (human monoclonal 17.1.41 heavy chain), disulfide …
Matched Description: … to the hepatitis B virus (HBV) surface antigen. ... It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies …
Matched Description: … to the hepatitis B virus (HBV) surface antigen. ... It is one of the active ingredients in HepeX-B, a drug product containing two human monoclonal antibodies …
PDPSC18
PDPSC18 is therapeutic DNA vaccine designed to fight chronic infections with the Hepatitis B virus, entering phase I clinical trials.
Investigational
Matched Description: … PDPSC18 is therapeutic DNA vaccine designed to fight chronic infections with the Hepatitis B virus, entering …
XTL-001
XTL001 is an investigational monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV).
Investigational
Matched International brands: … HepeX-B …
Matched Description: … antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV). ... monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Description: … antiviral activity of the compound in patients chronically infected with hepatitis B virus (HBV). ... monoclonal antibody (MAb) product developed by XTL Biopharmaceuticals to evaluate the safety profile and …
Matched Categories: … Amino Acids, Peptides, and Proteins …
LioCyx-M004
LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific T cell receptor.
Investigational
Matched Description: … LioCyx-M004 are autologous T cells transduced with a retroviral vector encoding a hepatitis B virus antigen-specific …
GI-5005
GI-5005 is GlobeImmune's lead infectious disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis C infection. GI-5005 is whole, heat-killed recombinant yeast genetically modified to express HCV-specific protein targets. Tarmogens are believed to activate both an innate immune response via Toll-like receptors (TLRs), as...
Investigational
Matched Description: … GI-5005 is whole, heat-killed recombinant yeast genetically modified to express HCV-specific protein ... disease product from its proprietary Tarmogen active immunotherapy platform for the treatment of chronic hepatitis ... to activate both an innate immune response via Toll-like receptors (TLRs), as well as an adaptive, antigen …
Matched Categories: … Amino Acids, Peptides, and Proteins …
Matched Categories: … Amino Acids, Peptides, and Proteins …
ISS-1018
ISS 1018 is a short, synthetic, unmethylated CpG oligodeoxynucleotide (CpG ODN) with immunostimulatory activity. ISS 1018 signals through Toll-like receptor 9 (TLR9) to induce the production of immunoglobulin by B cells and interferon (IFN) -alpha, IFN-beta, interleukin-12 (IL-12), and tumor necrosis factor - alpha (TNF-alpha) by plasmacytoid dendritic cells (pDC)....
Investigational
Matched Description: … for to prevent Hepatitis B in adults. ... ISS 1018 is currently being investigated in combination with HBsAg vaccine as a prophylactic treatment ... ISS 1018 CpG ODN promotes antigen presentation and co-stimulatory molecule expression. …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
Matched Categories: … Nucleic Acids, Nucleotides, and Nucleosides …
QS-21
QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies that is designed to enhance the body’s immune response to the antigen contained within the treatment. It is the leading member of the Stimulon family of adjuvants. As a vaccine additive, it is currently being...
Investigational
Matched Description: … QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies ... that is designed to enhance the body’s immune response to the antigen contained within the treatment ... As a vaccine additive, it is currently being evaluated in clinical trials in a variety of disease areas …
Displaying all 19 drugs